These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 15713280

  • 1. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ, ter Laak MP, Kamal A, Gispen WH.
    Brain Res; 2005 Feb 21; 1035(1):86-93. PubMed ID: 15713280
    [Abstract] [Full Text] [Related]

  • 2. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
    Manschot SM, Gispen WH, Kappelle LJ, Biessels GJ.
    Diabetes Metab Res Rev; 2003 Feb 21; 19(6):469-77. PubMed ID: 14648806
    [Abstract] [Full Text] [Related]

  • 3. The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ, Smale S, Duis SE, Kamal A, Gispen WH.
    J Neurol Sci; 2001 Jan 01; 182(2):99-106. PubMed ID: 11137514
    [Abstract] [Full Text] [Related]

  • 4. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ.
    Exp Neurol; 2001 Apr 01; 168(2):259-72. PubMed ID: 11259114
    [Abstract] [Full Text] [Related]

  • 5. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.
    Mizisin AP, Calcutt NA, Tomlinson DR, Gallagher A, Fernyhough P.
    J Peripher Nerv Syst; 1999 Apr 01; 4(3-4):211-21. PubMed ID: 10642089
    [Abstract] [Full Text] [Related]

  • 6. Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy.
    Piriz J, Torres-Aleman I, Nuñez A.
    Neuroscience; 2009 May 05; 160(2):402-11. PubMed ID: 19264110
    [Abstract] [Full Text] [Related]

  • 7. Synaptic transmission changes in the pyramidal cells of the hippocampus in streptozotocin-induced diabetes mellitus in rats.
    Kamal A, Biessels GJ, Gispen WH, Ramakers GM.
    Brain Res; 2006 Feb 16; 1073-1074():276-80. PubMed ID: 16455062
    [Abstract] [Full Text] [Related]

  • 8. Preserved LTP and water maze learning in hyperglycaemic-hyperinsulinemic ZDF rats.
    Bélanger A, Lavoie N, Trudeau F, Massicotte G, Gagnon S.
    Physiol Behav; 2004 Dec 15; 83(3):483-94. PubMed ID: 15581671
    [Abstract] [Full Text] [Related]

  • 9. Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus.
    Artola A, Kamal A, Ramakers GM, Biessels GJ, Gispen WH.
    Eur J Neurosci; 2005 Jul 15; 22(1):169-78. PubMed ID: 16029206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.
    Kappelle AC, Biessels G, Bravenboer B, van Buren T, Traber J, de Wildt DJ, Gispen WH.
    Br J Pharmacol; 1994 Mar 15; 111(3):887-93. PubMed ID: 8019766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An early diagnostic tool for diabetic neuropathy: conduction velocity distribution.
    Tuncer S, Dalkilic N, Esen HH, Avunduk MC.
    Muscle Nerve; 2011 Feb 15; 43(2):237-44. PubMed ID: 21254089
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment.
    Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH.
    Brain Res; 1998 Jul 27; 800(1):125-35. PubMed ID: 9685609
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats.
    Manschot SM, Biessels GJ, Cameron NE, Cotter MA, Kamal A, Kappelle LJ, Gispen WH.
    Brain Res; 2003 Mar 21; 966(2):274-82. PubMed ID: 12618350
    [Abstract] [Full Text] [Related]

  • 18. Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.
    Kappelle AC, Bravenboer B, van Buren T, Traber J, Erkelens DW, Gispen WH.
    Br J Pharmacol; 1993 Mar 21; 108(3):780-5. PubMed ID: 8467365
    [Abstract] [Full Text] [Related]

  • 19. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
    Nangle MR, Gibson TM, Cotter MA, Cameron NE.
    Planta Med; 2006 May 21; 72(6):494-500. PubMed ID: 16773532
    [Abstract] [Full Text] [Related]

  • 20. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA, Cameron NE, Hohman TC.
    J Peripher Nerv Syst; 1998 May 21; 3(3):217-23. PubMed ID: 10959252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.